RCM
LSTA icon

Rotella Capital Management’s Lisata Therapeutics LSTA Stock Holding History

Rotella Capital Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-75
Closed -$62K – 406
2014
Q3 		$62K Sell
75
-24
-24% -$21K 0.07% 226
2014
Q2 		$97K Buy
99
+23
+30% +$22.4K 0.08% 226
2014
Q1 		$80K Buy
+76
New +$82.4K 0.1% 124

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Rotella Capital Management's LSTA Position: Q4 2014 in Review

Rotella Capital Management sold out of Lisata Therapeutics (LSTA) in Q4 2014, closing a stake of 75 shares — an estimated $62K sold.

Rotella Capital Management first reported a position in LSTA in Q1 2014 and held it in 3 quarters. The position peaked at $97K in Q2 2014. 50 funds tracked by Wall St. Rank hold LSTA as of Q4 2014.

  • Rotella Capital Management reported no remaining Lisata Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Rotella Capital Management sold 75 Lisata Therapeutics shares in Q4 2014, an estimated $62K.
  • Rotella Capital Management first reported a position in Lisata Therapeutics in Q1 2014 and held it in 3 quarters.
  • Rotella Capital Management's Lisata Therapeutics position peaked at $97K in Q2 2014.
  • 50 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2014.

Based on Rotella Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.